Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 853,000 | 593,012 | 977,402 | 1,012,586 | 997,000 |
| Cost of Goods | 456,000 | 349,849 | 453,174 | 458,977 | 429,000 |
| Gross Profit | 397,000 | 243,163 | 524,227 | 553,610 | 568,000 |
| Operating Expenses | 356,000 | 270,877 | 364,936 | 353,187 | 363,000 |
| Operating Income | 40,000 | -26,865 | 159,466 | 201,400 | 205,000 |
| Interest Expense | 14,000 | 8,997 | 10,573 | 10,431 | 10,000 |
| Other Income | 32,000 | 13,032 | 23,912 | 20,056 | 28,000 |
| Pre-tax Income | 58,000 | -22,830 | 172,805 | 211,025 | 223,000 |
| Income Tax | 12,000 | -12,513 | 39,570 | 46,943 | 58,000 |
| Net Income Continuous | 46,000 | -10,317 | 133,235 | 164,082 | 165,000 |
| Minority Interests | -1,000 | 458 | -2,262 | -1,196 | -1,000 |
| Net Income | $47,000 | $-10,776 | $135,498 | $165,278 | $166,000 |
| EPS Basic Total Ops | 0.06 | -0.01 | 0.16 | 0.20 | 0.20 |
| EPS Basic Continuous Ops | 0.06 | -0.01 | 0.16 | 0.20 | 0.20 |
| EPS Diluted Total Ops | 0.06 | -0.01 | 0.16 | 0.20 | 0.20 |
| EPS Diluted Continuous Ops | 0.06 | -0.01 | 0.16 | 0.20 | 0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.06 | 0.16 | 0.19 | 0.20 |
| EBITDA(a) | $98,000 | $26,135 | $215,466 | $256,400 | $261,000 |